nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse effects of prolactin in rodents and humans: breast and prostate cancer
|
Harvey, Philip W. |
|
2008 |
|
2_suppl |
p. 20-27 |
artikel |
2 |
Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia
|
O'Keane, Veronica |
|
2008 |
|
2_suppl |
p. 70-75 |
artikel |
3 |
Antipsychotics and hyperprolactinaemia: Clinical recommendations
|
Peveler, Robert C |
|
2008 |
|
2_suppl |
p. 98-103 |
artikel |
4 |
A review of the association between antipsychotic use and hyperprolactinaemia
|
Bushe, Chris |
|
2008 |
|
2_suppl |
p. 46-55 |
artikel |
5 |
A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders
|
Hellewell, Jonathan S. E. |
|
2006 |
|
2_suppl |
p. 39-45 |
artikel |
6 |
Can one predict the long-term outcome of hospitalized depressives?
|
Lee, Alan S. |
|
1992 |
|
2_suppl |
p. 300-303 |
artikel |
7 |
Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics
|
Bushe, Chris |
|
2008 |
|
2_suppl |
p. 56-62 |
artikel |
8 |
Chairman's introduction
|
Coppen, Alec |
|
1992 |
|
2_suppl |
p. 289-290 |
artikel |
9 |
Chairman's summary
|
Coppen, Alec |
|
1992 |
|
2_suppl |
p. 342 |
artikel |
10 |
Clinical questions and uncertainty — prolactin measurement in patients with schizophrenia and bipolar disorder
|
Walters, James |
|
2008 |
|
2_suppl |
p. 82-89 |
artikel |
11 |
Current guidelines and their recommendations for prolactin monitoring in psychosis
|
Citrome, Leslie |
|
2008 |
|
2_suppl |
p. 90-97 |
artikel |
12 |
Discussion
|
|
|
1992 |
|
2_suppl |
p. 340-341 |
artikel |
13 |
Epidemiology of suicide and parasuicide
|
Platt, Stephen |
|
1992 |
|
2_suppl |
p. 291-299 |
artikel |
14 |
Introduction
|
Goodwin, GM |
|
2010 |
|
2_suppl |
p. 2 |
artikel |
15 |
Introduction: Newcastle consensus group on the aftermath of mania
|
Turner, Martin |
|
2006 |
|
2_suppl |
p. 3 |
artikel |
16 |
Lithium in maintenance therapy for bipolar disorder
|
Young, Allan H. |
|
2006 |
|
2_suppl |
p. 17-22 |
artikel |
17 |
Managing the aftermath of mania - Newcastle, 2 September 2005: Consensus Meeting Statement
|
Young, Allan H. |
|
2006 |
|
2_suppl |
p. 51-54 |
artikel |
18 |
Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists
|
Holt, Richard IG |
|
2008 |
|
2_suppl |
p. 28-37 |
artikel |
19 |
Olanzapine - relapse prevention following mania
|
Dando, Simon |
|
2006 |
|
2_suppl |
p. 31-38 |
artikel |
20 |
Pharmacotherapy of depressive disorders. A consensus statement
|
|
|
1992 |
|
2_suppl |
p. 343-344 |
artikel |
21 |
Pituitary volume in psychosis: the first review of the evidence
|
Pariante, Carmine M. |
|
2008 |
|
2_suppl |
p. 76-81 |
artikel |
22 |
Practical aspects of long-term treatment with lithium
|
Glen, Iain |
|
1992 |
|
2_suppl |
p. 330-333 |
artikel |
23 |
Prolactin and dopamine: What is the connection? A Review Article
|
Fitzgerald, Peter |
|
2008 |
|
2_suppl |
p. 12-19 |
artikel |
24 |
Psychotherapy for bipolar disorders - efficacy and effectiveness
|
Scott, Jan |
|
2006 |
|
2_suppl |
p. 46-50 |
artikel |
25 |
Reduction in the incidence of suicide: a health gain objective for the NHS
|
Todd, Christopher J. |
|
1992 |
|
2_suppl |
p. 318-324 |
artikel |
26 |
Relapse prevention in bipolar disorder: a critical review of current guidelines
|
McAllister-Williams, R. Hamish |
|
2006 |
|
2_suppl |
p. 12-16 |
artikel |
27 |
Review: Clock genes at the heart of depression
|
Kennaway, David J |
|
2010 |
|
2_suppl |
p. 5-14 |
artikel |
28 |
Review: Restoring circadian rhythms: a new way to successfully manage depression
|
Gorwood, Philip |
|
2010 |
|
2_suppl |
p. 15-19 |
artikel |
29 |
Review: The antidepressant agomelatine improves the quality of life of depressed patients: implications for remission
|
Llorca, Pierre-Michel |
|
2010 |
|
2_suppl |
p. 21-26 |
artikel |
30 |
Review: The importance of early symptom relief in antidepressant treatment: focus on agomelatine
|
Lam, Raymond W |
|
2010 |
|
2_suppl |
p. 27-30 |
artikel |
31 |
Serotonin, sertraline and depression
|
Montgomery, Stuart |
|
1995 |
|
2_suppl |
p. 179-184 |
artikel |
32 |
The anxiety factor in depression
|
Nutt, David |
|
1995 |
|
2_suppl |
p. 185-189 |
artikel |
33 |
The effects of treatment on mortality in affective illness
|
Goodwin, Guy M. |
|
1992 |
|
2_suppl |
p. 312-317 |
artikel |
34 |
The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness
|
Dursun, Serdar M |
|
2008 |
|
2_suppl |
p. 3-5 |
artikel |
35 |
The evolution of hyperprolactinaemia as an entity in psychiatric patients
|
Kohen, Dora |
|
2008 |
|
2_suppl |
p. 6-11 |
artikel |
36 |
The evolution of lithium therapy
|
Johnson, F.Neil |
|
1992 |
|
2_suppl |
p. 325-329 |
artikel |
37 |
The impact of hyperprolactinaemia on sexual function in patients with psychosis
|
Smith, Shubulade M |
|
2008 |
|
2_suppl |
p. 63-69 |
artikel |
38 |
The long-term management of depression
|
Lane, Roger |
|
1995 |
|
2_suppl |
p. 191-198 |
artikel |
39 |
The management of patients at risk for suicide
|
Abou-Saleh, Mohammed T. |
|
1992 |
|
2_suppl |
p. 304-311 |
artikel |
40 |
The prevention of suicide in patients with recurrent mood disorder
|
Peet, Malcolm |
|
1992 |
|
2_suppl |
p. 334-339 |
artikel |
41 |
The SSRIs: advantages, disadvantages and differences
|
Lane, Roger |
|
1995 |
|
2_suppl |
p. 163-178 |
artikel |
42 |
The use of anticonvulsants in the aftermath of mania
|
Cookson, John |
|
2006 |
|
2_suppl |
p. 23-30 |
artikel |
43 |
Treatment approaches to therapy-resistant depression
|
Dinan, Ted |
|
1995 |
|
2_suppl |
p. 199-204 |
artikel |
44 |
Understanding osteoporosis
|
Javaid, M Kassim |
|
2008 |
|
2_suppl |
p. 38-45 |
artikel |
45 |
What does history teach us about factors associated with relapse in bipolar affective disorder?
|
Tyrer, Stephen |
|
2006 |
|
2_suppl |
p. 4-11 |
artikel |